Skip to content

Therapeutic effect of Norepinephrine combined with low dose Terlipressin on septic shock

Therapeutic effect of Norepinephrine combined with low dose Terlipressin on septic shock: a randomized multicenter controlled study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063359
Enrollment
Unknown
Registered
2022-09-05
Start date
2022-09-01
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

septic shock

Interventions

2groups:Continuous infusion of terlipressin

Sponsors

The First Affiliated Hospital of University of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. 18 to 80 years old. 2. Meet the diagnostic criteria for septic shock. 3. Noradrenaline/dopamine use time < 4h at admission

Exclusion criteria

Exclusion criteria: 1. less than 18 years or more than 80 years; 2. ACS (acute myocardial infarction during shock); 3. Severe arrhythmia; 4, previously used terlipressin during the current ICU admission. 5. Patients have been combined with multiple organ dysfunction at admission, and the clinical outcome predicts a mortality risk greater than 90% (according to APACHE II score calculation formula: In (R/1-R) = -3.517 + (APACHE II score × 0.146) + 0.603 (limited to patients after emergency surgery) + patients' main disease score admitted to the ICU). 6. Pregnant. 7. Confirmed or suspected acute mesenteric ischemia, Raynaud 's phenomenon; 8. Organ transplantation. 9. Shock caused by non-infectious factors. 10. Hyperthyroidism. 11. Severe intracranial hypertension; 12. Patients receiving organ transplantation. 13. The infection focus is not effectively controlled, such as biliary tract infection without drainage, empyema without puncture drainage, kidney abscess without surgery.

Design outcomes

Primary

MeasureTime frame
The incidence of acute kidney injury;CRRT Usage;

Secondary

MeasureTime frame
SOFA;Mortality 28 days;

Countries

China

Contacts

Public ContactTianjun Yang

The First Affiliated Hospital of University of Science and Technology of China

576900430@qq.com+86 13485516670

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026